Business Description
Nidan Laboratories and Healthcare Ltd
ISIN : INE0J6L01013
Compare
Compare
Traded in other countries / regions
NIDAN.India IPO Date
2021-11-12Description
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.25 | |||||
| Debt-to-EBITDA | 1.73 | |||||
| Interest Coverage | 1.84 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.61 | |||||
| Beneish M-Score | -0.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.9 | |||||
| 3-Year EBITDA Growth Rate | -36 | |||||
| 3-Year EPS without NRI Growth Rate | -12.1 | |||||
| 3-Year Book Growth Rate | 73.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.41 | |||||
| 9-Day RSI | 43.4 | |||||
| 14-Day RSI | 45.41 | |||||
| 6-1 Month Momentum % | -14.91 | |||||
| 12-1 Month Momentum % | -14.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.67 | |||||
| Quick Ratio | 2.65 | |||||
| Cash Ratio | 0.25 | |||||
| Days Inventory | 111.8 | |||||
| Days Sales Outstanding | 49.27 | |||||
| Days Payable | 244.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 5.86 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 95.51 | |||||
| Operating Margin % | 15.92 | |||||
| Net Margin % | 14.59 | |||||
| FCF Margin % | 42.45 | |||||
| ROE % | 5.23 | |||||
| ROA % | 4.24 | |||||
| ROIC % | 3.66 | |||||
| ROC (Joel Greenblatt) % | 20.51 | |||||
| ROCE % | 9.46 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 30.44 | |||||
| PS Ratio | 1.67 | |||||
| PB Ratio | 0.58 | |||||
| Price-to-Tangible-Book | 0.58 | |||||
| Price-to-Free-Cash-Flow | 3.92 | |||||
| Price-to-Operating-Cash-Flow | 3.68 | |||||
| EV-to-EBIT | 7.96 | |||||
| EV-to-EBITDA | 5.49 | |||||
| EV-to-Revenue | 2.27 | |||||
| EV-to-FCF | 5.41 | |||||
| Price-to-Graham-Number | 0.64 | |||||
| Price-to-Net-Current-Asset-Value | 2.36 | |||||
| Earnings Yield (Greenblatt) % | 12.56 | |||||
| FCF Yield % | 25.46 | |||||
| Forward Rate of Return (Yacktman) % | -8.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nidan Laboratories and Healthcare Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 242.659 | ||
| EPS (TTM) (₹) | -2.33 | ||
| Beta | 0.23 | ||
| Volatility % | 35.02 | ||
| 14-Day RSI | 45.41 | ||
| 14-Day ATR (₹) | 0.878583 | ||
| 20-Day SMA (₹) | 29.2875 | ||
| 12-1 Month Momentum % | -14.91 | ||
| 52-Week Range (₹) | 27 - 41.15 | ||
| Shares Outstanding (Mil) | 13.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nidan Laboratories and Healthcare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nidan Laboratories and Healthcare Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nidan Laboratories and Healthcare Ltd Frequently Asked Questions
What is Nidan Laboratories and Healthcare Ltd(NSE:NIDAN)'s stock price today?
The current price of NSE:NIDAN is ₹29.10. The 52 week high of NSE:NIDAN is ₹41.15 and 52 week low is ₹27.00.
When is next earnings date of Nidan Laboratories and Healthcare Ltd(NSE:NIDAN)?
The next earnings date of Nidan Laboratories and Healthcare Ltd(NSE:NIDAN) is .
Does Nidan Laboratories and Healthcare Ltd(NSE:NIDAN) pay dividends? If so, how much?
Nidan Laboratories and Healthcare Ltd(NSE:NIDAN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers